#United States #New York #Levi & Korsinsky #Securities Fraud #PepGen Inc.

PepGen Inc. Faces Legal Action

In a significant legal development, PepGen Inc. has been served with a class action lawsuit related to allegations of securities fraud. The legal firm Levi & Korsinsky LLP has taken the initiative to notify affected investors that they have recourse under the law, particularly regarding past claims of misinformation from the company. This lawsuit could have major implications for shareholders who experienced losses during the specified period.

Background of the Case

The complaint arises from alleged misleading statements made by PepGen Inc. regarding its lead product candidate, PGN-EDO51. According to the lawsuit, the company reportedly misrepresented the efficacy and safety of PGN-EDO51, misguiding investors into believing in its clinical and commercial prospects when, in fact, they were overstated. Notably, the period under scrutiny stretches from March 7, 2024, to March 3, 2025.

The allegations further suggest that the Phase Two clinical study, CONNECT2, was fraught with challenges that the company failed to communicate adequately. Investors are being informed that PepGen may have suspended the CONNECT2 study, lending credibility to the claims that important information was inadequately disclosed to the public.

Legal Implications for Investors

Investors who have suffered losses during this period should act fast and consider engaging with legal representatives to determine their rights and options. The firm has highlighted that individuals have until August 8, 2025, to apply for lead plaintiff status in the class action suit. While taking on this role might be appealing, participation in the class doesn't require one to be a lead plaintiff, making it easier for a wider range of affected individuals to seek restitution.

No Costs for Participation

A crucial aspect of this legal proceeding is that there are no upfront costs for investors to participate in the class action lawsuit. Those who are classified as members of the class may receive damages without having to pay out-of-pocket expenses. Levi & Korsinsky assures potential claimants that there is no obligation or monetary requirement to pursue compensation through this lawsuit.

The Role of Levi & Korsinsky

Levi & Korsinsky LLP boasts extensive experience in complex securities litigation, having successfully secured numerous settlements for shareholders over the past two decades. Their reputation is built on a consistent track record of navigating intricate legal landscapes on behalf of their clients. Notably, the firm has been recognized repeatedly in securities class action rankings and continues to serve a broad client base seeking justice.

Next Steps for Affected Investors

For investors concerned about their stakes in PepGen Inc., it is paramount to act swiftly. Interested parties are encouraged to reach out to Levi & Korsinsky to discuss their situations and gather more information about potential claims. Contact can be initiated via email or through the firm’s dedicated hotline, allowing for a direct line of communication with experienced attorneys.

The clock is ticking, and time is of the essence. This case serves as a reminder for investors to stay vigilant regarding disclosures from public companies and the inherent risks of being misled about product efficacy and corporate statements.

For further detailed information about participating in the class action lawsuit against PepGen, please visit the firm’s webpage or contact them via the listed communication channels. Protecting investor rights is vital, and seeking legal advice could be a necessary step in obtaining justice in this compelling matter.